<![CDATA[19 Targeted Axillary Dissection—Does the Biopsy-Proven Node Need to Be Localized? A Retrospective Review of Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy]]>

Summary

A retrospective review demonstrates that targeted axillary dissection with sentinel lymph node biopsy successfully identified preoperatively positive nodes in node-positive breast cancer patients treated with neoadjuvant chemotherapy, with no axillary recurrences reported.